Literature DB >> 10131886

Measuring resource use in economic evaluations: determining the social costs of mental illness.

R E Clark1, G B Teague, S K Ricketts, P W Bush, A M Keller, M Zubkoff, R E Drake.   

Abstract

Concern over costs associated with mental disorders has led to an increase in the number of economic evaluations of treatment interventions; unfortunately, methods for measuring resource use have not kept pace with this concern. Although it is well-known that a significant proportion of the costs associated with mental illness are for resources other than treatment, program evaluators and researchers often count only treatment costs in cost-effectiveness comparisons. Further, existing methods for measuring resource use are plagued by faulty assumptions about resource use, poor validity and reliability, and difficulties quantifying resource use. The authors discuss these problems and suggest five ways of improving measurement of nontreatment resources: clarifying assumptions, using multiple data sources, flexible data collection strategies, methods for improving the accuracy of recall, and an episodic approach to measurement.

Entities:  

Mesh:

Year:  1994        PMID: 10131886     DOI: 10.1007/BF02521343

Source DB:  PubMed          Journal:  J Ment Health Adm        ISSN: 0092-8623


  20 in total

1.  Recall strategies and memory for health-care visits.

Authors:  J B Jobe; A A White; C L Kelley; D J Mingay; M J Sanchez; E F Loftus
Journal:  Milbank Q       Date:  1990       Impact factor: 4.911

Review 2.  Family burden and family stigma in major mental illness.

Authors:  H P Lefley
Journal:  Am Psychol       Date:  1989-03

3.  Relationship between utilization of mental health and medical services in a VA hospital.

Authors:  P M Massad; A N West; M J Friedman
Journal:  Am J Psychiatry       Date:  1990-04       Impact factor: 18.112

4.  Expenditures of time and money by families of people with severe mental illness and substance use disorders.

Authors:  R E Clark; R E Drake
Journal:  Community Ment Health J       Date:  1994-04

5.  A guide to benefit-cost analysis, as seen through a controlled experiment in treating the mentally ill.

Authors:  B A Weisbrod
Journal:  J Health Polit Policy Law       Date:  1983       Impact factor: 2.265

6.  Criminalizing mental disorder. The comparative arrest rate of the mentally ill.

Authors:  L A Teplin
Journal:  Am Psychol       Date:  1984-07

7.  Cost measurement and cost data in mental health settings.

Authors:  J Rubin
Journal:  Hosp Community Psychiatry       Date:  1982-09

8.  Mental health cost models. Refinements and applications.

Authors:  B Dickey; T G McGuire; N L Cannon; J E Gudeman
Journal:  Med Care       Date:  1986-09       Impact factor: 2.983

9.  The prevalence of severe mental disorder among male urban jail detainees: comparison with the Epidemiologic Catchment Area Program.

Authors:  L A Teplin
Journal:  Am J Public Health       Date:  1990-06       Impact factor: 9.308

Review 10.  The epidemiology of alcohol, drug, and mental disorders among homeless persons.

Authors:  P J Fischer; W R Breakey
Journal:  Am Psychol       Date:  1991-11
View more
  6 in total

1.  Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders.

Authors:  R E Clark; G B Teague; S K Ricketts; P W Bush; H Xie; T G McGuire; R E Drake; G J McHugo; A M Keller; M Zubkoff
Journal:  Health Serv Res       Date:  1998-12       Impact factor: 3.402

2.  Longitudinal Course of Clients With Co-occurring Schizophrenia-Spectrum and Substance Use Disorders in Urban Mental Health Centers: A 7-Year Prospective Study.

Authors:  Robert E Drake; Alison E Luciano; Kim T Mueser; Nancy H Covell; Susan M Essock; Haiyi Xie; Gregory J McHugo
Journal:  Schizophr Bull       Date:  2015-08-19       Impact factor: 9.306

3.  Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders.

Authors:  Mary F Brunette; Robert E Drake; Haiyi Xie; Gregory J McHugo; Alan I Green
Journal:  Schizophr Bull       Date:  2006-06-16       Impact factor: 9.306

4.  A randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophrenia.

Authors:  Mary F Brunette; Ree Dawson; Christopher D O'Keefe; Meera Narasimhan; Douglas L Noordsy; Joanne Wojcik; Alan I Green
Journal:  J Dual Diagn       Date:  2011

5.  Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials.

Authors:  Hildegard Seidl; Christa Meisinger; Rupert Wende; Rolf Holle
Journal:  BMC Health Serv Res       Date:  2012-09-15       Impact factor: 2.655

Review 6.  Aspects and Challenges of Resource Use Measurement in Health Economics: Towards a Comprehensive Measurement Framework.

Authors:  Luca M M Janssen; Ruben M W A Drost; Aggie T G Paulus; Kirsty Garfield; William Hollingworth; Sian Noble; Joanna C Thorn; Irina Pokhilenko; Silvia M A A Evers
Journal:  Pharmacoeconomics       Date:  2021-06-25       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.